The constructive nature of a matured Forum is to exchange opinions and provide intellectual information. I for one welcome any respectful contradictions to whatever messages on the board with matured and professionalism. Not just mouthing unintelligible Trumpism, without evidence and merits and be booted out unceremoniously. Not like someone with more than 2600+ postings or were they just one lined stand-up comedian jokes?

So are you calling a SELL, Keyman? The Music has stopped? I maybe new to this Forum, but I have been dabbling in KLSE the past 30 years.

Post removed.Why?

Post removed.Why?

All 4 Vaccines in the approval stages requires 2 doses shots within 1 month. The production is very much lesser that the demands and book-orders for their motherland and local government. I may be wrong in assumption, but many countries many know see the likes of them before 2Q or even 3Q 2021. For Malaysians companies to have the Special Formula and transfer of Technologies, seems a bit far fetched as the basic requirements of expertise, facilities and the further certifications may take a much longer time. Also, humans have greed traits and if you have found a way to harness Gold from your garden mud, would you kindly share with us for FREE?

You are absolutely right, Jonathan. There is the imminent need to get vaccinated and immunisation to the levels of 70% population in order to have herd immunity. This level and nothing less can create the prevention, cutting the chains and to curtail the fast spreading deadly disease. Herd immunity corners the spike in numbers but is not an eradication or cure. The exposed 30% is still in much danger of infection and death, albeit at a much lesser numbers.

No doubt, your money is yours and how you wish to invest for whichever amount of return to sell the stocks is your own prerogatives.From the onset of the Virus Pandemic in March, we have held the notion that a vaccine/vaccines is imperative to ward off or protect under immunisation. A "cure" would take several years. On KLSE, we found these experienced, logical and almost natural processors to deliver, distribute the vaccine and with legitimate support from both Government and private sectors. We found P at RM1.65 and Dp at 1.55. How their prices grew exponentially at great PE ratios and stock accumulations are all history now. We look to the present and where they go from here, not backwards. For the records, Rubberex was at RM0.17 and on 2 Jan 2020, TG was at RM1.55 Not that Dp might emulate their spectacular ascend but surely they have the strong fundamentals and basis at their current valued prices.

Thank you, Salman. We are all here to share and not get our fingers burnt.

Should we take a step back and holistically view these penny stocks, many of they claimed to have signed MOU or started negotiations with the so-called "Distributors" from China. The MOU is just an understanding to proceed with further detailed negotiations, fact findings, terms setting for accordance to both parties. The MOU can be discarded or used as toilet paper the next minute after talks has failed. Why was there never any questions of the business being discussed with the manufacturer directly, or even appointed distributor??? Share prices run up fast and millions traded. I would have better faith and trust on FACTS rather than FIGURES.

Dp has been filling and distributing Insulin from their Bangi premise for decades. Their capability and the capacity (under utilised) is a resounding fact of what they have achieved over the years. Any new start-up facility to enter and compete in this industry might not be viable since Malaysia has a small population of only 31 million. In addition, the facilities is not just a small investments of several million ringgit but tens of millions if not a 100 million. Where is the ROI or the viability for such an undertaking?

Not to discriminate against Chinese Vaccines or pour cold water on them, the NPRA is very strict and not just a walk in the park to obtain. Further, CTIL from chinese vaccines are not completely reviewed and researched thoroughly. Our MREC, in accordance with MOH guidelines is also another great hurdle, since the immunisation is costly for chinese serum and at greater cost to lives.

Personally, the latest development on Vaccines are most likely shipped prepacked, even some pre-needled. To receive in bulk and re-bottled may expose to contamination/temperature control by least able pharma factories. Penny wise and leading the pack, P and Dp may have added factors in obtaining distributorship, being "Branded" and all others having trust deficits.

Moderna's vaccine, developed similarly to Pfizer-BioNTech's mRNA technology does not require storage at -70 to -80 degrees but their price is almost doubled at USD37 per shot. Moderna has 2 facilities, the one in US produces 500 million shots and the other in Swiss with 600 million shots per year...which brings deliveries to their present book-orders to the end of 2021.

I, for one find it hard to believe that Pfizer-BioNTech Vaccine could find supply for Malaysia during 1Q of 2021, even just 1 million shots for 500,000 population. Even as we speak, United Airlines are ferrying the Vaccine across USA, awaiting for FDA approval for Emergency use and to immediately start vaccination/immunisation the next day. (There's nearly 200,000 cases and 2,500 deaths daily) Challenges of transportation and storage under cold chain aside, their production capacity for their own country and those pre-orders are hard to fulfill.

Post removed.Why?

Just wondering...for all the Vaccines offered, they are already "filled and Packed" so why is Pharma and DPharma still required to upgrade their facilities? Also, Dpharma has been "filling and packing" Insulin for past decades.